Mesenchymal stem cells reverse thymus aging by reprogramming the DNA methylation of thymic epithelial cells

Background: A decrease in the number and activity of thymic epithelial cells (TECs) is an important factor in thymic degeneration. Mesenchymal stem cells (MSCs) treating thymic ageing is a promising strategy, but the DNA methylation modification mechanism in TECs remains unclear. Methods: Aged rhesu...

Full description

Bibliographic Details
Main Authors: Zailing Yang, Chuan Tian, Zhixu He, Xiangqing Zhu, Jie He, Hang Pan, Ye Li, Guangping Ruan, XiJun Wu, Xinghua Pan
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Regenerative Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352320424000397
_version_ 1827246288252436480
author Zailing Yang
Chuan Tian
Zhixu He
Xiangqing Zhu
Jie He
Hang Pan
Ye Li
Guangping Ruan
XiJun Wu
Xinghua Pan
author_facet Zailing Yang
Chuan Tian
Zhixu He
Xiangqing Zhu
Jie He
Hang Pan
Ye Li
Guangping Ruan
XiJun Wu
Xinghua Pan
author_sort Zailing Yang
collection DOAJ
description Background: A decrease in the number and activity of thymic epithelial cells (TECs) is an important factor in thymic degeneration. Mesenchymal stem cells (MSCs) treating thymic ageing is a promising strategy, but the DNA methylation modification mechanism in TECs remains unclear. Methods: Aged rhesus monkeys were treated with MSCs to establish a thymic senescence model, and hematoxylin-eosin (HE) staining, immunofluorescence staining, and ELISA were performed to observe the structure and function of the thymus. TEC aging model and MSCs co-culture system were established to detect DNA methylation modification and transcriptomic changes, correlation analysis between transcription factor methylation and mRNA expression, and q-PCR, immunofluorescence staining, and Western blot were used to identified key genes. Results: MSCs improved the structure and function of thymus in elderly macaque monkeys; reduced the expression levels of β-Gal, P16, and P21; and increased the activity of aging TECs. There were 501 genes with increased methylation in the promoter region in the treated group compared with the untreated group, among which 23 genes were involved in the negative regulation of cell growth, proliferation and apoptosis, while 591 genes had decreased methylation, among which 37 genes were associated with promoting cell growth and proliferation and inhibiting apoptosis. Furthermore, 66 genes showed a negative correlation between promoter methylation levels and gene transcription; specifically, PDE5A, DUOX2, LAMP1 and SVIL were downregulated with increased methylation, inhibiting growth and development, while POLR3G, PGF, CHTF18, KRT17, FOXJ1, NGF, DYRK3, LRP8, CDT1, PRELID1, F2R, KNTC1 and TRIM3 were upregulated with decreased methylation, promoting cell growth. Conclusion: MSCs improve the structure and function of aged thymus, which involves the regulation of DNA methylation profiles and a decrease in the methylation level of the transcription factor NGF to specifically upregulate KRT17 and FOXJ1 to promote the proliferation of TECs.
first_indexed 2024-04-24T18:47:29Z
format Article
id doaj.art-7ee33dd2d9ce4ab89356c16d854c398e
institution Directory Open Access Journal
issn 2352-3204
language English
last_indexed 2025-03-21T22:57:34Z
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Regenerative Therapy
spelling doaj.art-7ee33dd2d9ce4ab89356c16d854c398e2024-05-23T04:56:14ZengElsevierRegenerative Therapy2352-32042024-12-0127126169Mesenchymal stem cells reverse thymus aging by reprogramming the DNA methylation of thymic epithelial cellsZailing Yang0Chuan Tian1Zhixu He2Xiangqing Zhu3Jie He4Hang Pan5Ye Li6Guangping Ruan7XiJun Wu8Xinghua Pan9The Basic Medical Laboratory of the 920th Hospital of Joint Logistics Support Force of PLA, The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, China; The Second People's Hospital of Guiyang, Medical Laboratory, Guiyang 550023, Guizhou Province, ChinaThe Basic Medical Laboratory of the 920th Hospital of Joint Logistics Support Force of PLA, The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, ChinaDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, ChinaThe Basic Medical Laboratory of the 920th Hospital of Joint Logistics Support Force of PLA, The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, ChinaThe Basic Medical Laboratory of the 920th Hospital of Joint Logistics Support Force of PLA, The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, ChinaThe Basic Medical Laboratory of the 920th Hospital of Joint Logistics Support Force of PLA, The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, ChinaThe Basic Medical Laboratory of the 920th Hospital of Joint Logistics Support Force of PLA, The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, ChinaThe Basic Medical Laboratory of the 920th Hospital of Joint Logistics Support Force of PLA, The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, ChinaThe Second People's Hospital of Guiyang, Medical Laboratory, Guiyang 550023, Guizhou Province, China; Corresponding author.The Basic Medical Laboratory of the 920th Hospital of Joint Logistics Support Force of PLA, The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, China; Corresponding author.Background: A decrease in the number and activity of thymic epithelial cells (TECs) is an important factor in thymic degeneration. Mesenchymal stem cells (MSCs) treating thymic ageing is a promising strategy, but the DNA methylation modification mechanism in TECs remains unclear. Methods: Aged rhesus monkeys were treated with MSCs to establish a thymic senescence model, and hematoxylin-eosin (HE) staining, immunofluorescence staining, and ELISA were performed to observe the structure and function of the thymus. TEC aging model and MSCs co-culture system were established to detect DNA methylation modification and transcriptomic changes, correlation analysis between transcription factor methylation and mRNA expression, and q-PCR, immunofluorescence staining, and Western blot were used to identified key genes. Results: MSCs improved the structure and function of thymus in elderly macaque monkeys; reduced the expression levels of β-Gal, P16, and P21; and increased the activity of aging TECs. There were 501 genes with increased methylation in the promoter region in the treated group compared with the untreated group, among which 23 genes were involved in the negative regulation of cell growth, proliferation and apoptosis, while 591 genes had decreased methylation, among which 37 genes were associated with promoting cell growth and proliferation and inhibiting apoptosis. Furthermore, 66 genes showed a negative correlation between promoter methylation levels and gene transcription; specifically, PDE5A, DUOX2, LAMP1 and SVIL were downregulated with increased methylation, inhibiting growth and development, while POLR3G, PGF, CHTF18, KRT17, FOXJ1, NGF, DYRK3, LRP8, CDT1, PRELID1, F2R, KNTC1 and TRIM3 were upregulated with decreased methylation, promoting cell growth. Conclusion: MSCs improve the structure and function of aged thymus, which involves the regulation of DNA methylation profiles and a decrease in the methylation level of the transcription factor NGF to specifically upregulate KRT17 and FOXJ1 to promote the proliferation of TECs.http://www.sciencedirect.com/science/article/pii/S2352320424000397Thymus agingMSCsTECsDNA methylation
spellingShingle Zailing Yang
Chuan Tian
Zhixu He
Xiangqing Zhu
Jie He
Hang Pan
Ye Li
Guangping Ruan
XiJun Wu
Xinghua Pan
Mesenchymal stem cells reverse thymus aging by reprogramming the DNA methylation of thymic epithelial cells
Regenerative Therapy
Thymus aging
MSCs
TECs
DNA methylation
title Mesenchymal stem cells reverse thymus aging by reprogramming the DNA methylation of thymic epithelial cells
title_full Mesenchymal stem cells reverse thymus aging by reprogramming the DNA methylation of thymic epithelial cells
title_fullStr Mesenchymal stem cells reverse thymus aging by reprogramming the DNA methylation of thymic epithelial cells
title_full_unstemmed Mesenchymal stem cells reverse thymus aging by reprogramming the DNA methylation of thymic epithelial cells
title_short Mesenchymal stem cells reverse thymus aging by reprogramming the DNA methylation of thymic epithelial cells
title_sort mesenchymal stem cells reverse thymus aging by reprogramming the dna methylation of thymic epithelial cells
topic Thymus aging
MSCs
TECs
DNA methylation
url http://www.sciencedirect.com/science/article/pii/S2352320424000397
work_keys_str_mv AT zailingyang mesenchymalstemcellsreversethymusagingbyreprogrammingthednamethylationofthymicepithelialcells
AT chuantian mesenchymalstemcellsreversethymusagingbyreprogrammingthednamethylationofthymicepithelialcells
AT zhixuhe mesenchymalstemcellsreversethymusagingbyreprogrammingthednamethylationofthymicepithelialcells
AT xiangqingzhu mesenchymalstemcellsreversethymusagingbyreprogrammingthednamethylationofthymicepithelialcells
AT jiehe mesenchymalstemcellsreversethymusagingbyreprogrammingthednamethylationofthymicepithelialcells
AT hangpan mesenchymalstemcellsreversethymusagingbyreprogrammingthednamethylationofthymicepithelialcells
AT yeli mesenchymalstemcellsreversethymusagingbyreprogrammingthednamethylationofthymicepithelialcells
AT guangpingruan mesenchymalstemcellsreversethymusagingbyreprogrammingthednamethylationofthymicepithelialcells
AT xijunwu mesenchymalstemcellsreversethymusagingbyreprogrammingthednamethylationofthymicepithelialcells
AT xinghuapan mesenchymalstemcellsreversethymusagingbyreprogrammingthednamethylationofthymicepithelialcells